These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9781841

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Lipogenic action of the novel oral antidiabetic agent HQL-975 in genetically obese diabetic KK-Ay mice.
    Ishikawa Y, Takeno H, Watanabe K, Tani T.
    Biol Pharm Bull; 1999 Jun; 22(6):572-6. PubMed ID: 10408228
    [Abstract] [Full Text] [Related]

  • 4. Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin-dependent diabetes mellitus model animals.
    Ishikawa Y, Saito MN, Ikemoto T, Takeno H, Watanabe K, Tani T.
    Diabetes Res Clin Pract; 1998 Aug; 41(2):101-11. PubMed ID: 9789716
    [Abstract] [Full Text] [Related]

  • 5. Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.
    Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA.
    Diabetes; 1995 Sep; 44(9):1087-92. PubMed ID: 7657033
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice.
    Stevenson RW, Hutson NJ, Krupp MN, Volkmann RA, Holland GF, Eggler JF, Clark DA, McPherson RK, Hall KL, Danbury BH.
    Diabetes; 1990 Oct; 39(10):1218-27. PubMed ID: 2210074
    [Abstract] [Full Text] [Related]

  • 13. Comparison of PEGylated FGF-21 with insulin glargine for long-lasting hypoglycaemic effect in db/db mice.
    Ye X, Qi J, Wu Y, Yu D, Xu P, Li S, Zhu S, Wu Q, Ren G, Li D.
    Diabetes Metab; 2015 Feb; 41(1):82-90. PubMed ID: 25451186
    [Abstract] [Full Text] [Related]

  • 14. Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
    Han GC, Ko SK, Sung JH, Chung SH.
    J Agric Food Chem; 2007 Dec 26; 55(26):10641-8. PubMed ID: 18034458
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.
    Diabetes Obes Metab; 2007 Nov 26; 9(6):879-88. PubMed ID: 17924870
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4).
    Gibbs EM, Stock JL, McCoid SC, Stukenbrok HA, Pessin JE, Stevenson RW, Milici AJ, McNeish JD.
    J Clin Invest; 1995 Apr 26; 95(4):1512-8. PubMed ID: 7706456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.